Rank | Gene Set | Z-score |
---|---|---|
1 | alpha-linolenic acid metabolic process (GO:0036109) | 5.03534456 |
2 | hemidesmosome assembly (GO:0031581) | 4.63467536 |
3 | low-density lipoprotein particle clearance (GO:0034383) | 4.45572149 |
4 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.35836296 |
5 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.29918091 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.27836811 |
7 | L-phenylalanine catabolic process (GO:0006559) | 4.27836811 |
8 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.27698217 |
9 | complement activation, alternative pathway (GO:0006957) | 4.21889389 |
10 | membrane raft organization (GO:0031579) | 4.11817745 |
11 | protein localization to endosome (GO:0036010) | 4.11134181 |
12 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.08991516 |
13 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.08604197 |
14 | negative regulation of fibrinolysis (GO:0051918) | 4.07482014 |
15 | L-phenylalanine metabolic process (GO:0006558) | 4.04157750 |
16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.04157750 |
17 | urea metabolic process (GO:0019627) | 4.03053001 |
18 | urea cycle (GO:0000050) | 4.03053001 |
19 | desmosome organization (GO:0002934) | 4.00733366 |
20 | protein carboxylation (GO:0018214) | 3.97550384 |
21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.97550384 |
22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95510416 |
23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.92996613 |
24 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.92617290 |
25 | sulfur amino acid catabolic process (GO:0000098) | 3.89655895 |
26 | collagen fibril organization (GO:0030199) | 3.88003713 |
27 | Golgi transport vesicle coating (GO:0048200) | 3.83936587 |
28 | COPI coating of Golgi vesicle (GO:0048205) | 3.83936587 |
29 | COPII vesicle coating (GO:0048208) | 3.82091274 |
30 | regulation of protein activation cascade (GO:2000257) | 3.81409427 |
31 | aromatic amino acid family catabolic process (GO:0009074) | 3.77622331 |
32 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.74576914 |
33 | iron ion import (GO:0097286) | 3.71618698 |
34 | valine metabolic process (GO:0006573) | 3.69984217 |
35 | plasma lipoprotein particle clearance (GO:0034381) | 3.69700445 |
36 | regulation of complement activation (GO:0030449) | 3.68429532 |
37 | epoxygenase P450 pathway (GO:0019373) | 3.62601795 |
38 | regulation of fibrinolysis (GO:0051917) | 3.61594762 |
39 | cysteine metabolic process (GO:0006534) | 3.57428048 |
40 | nitrogen cycle metabolic process (GO:0071941) | 3.56145975 |
41 | substrate-dependent cell migration (GO:0006929) | 3.55585314 |
42 | skin morphogenesis (GO:0043589) | 3.54700770 |
43 | sphingosine metabolic process (GO:0006670) | 3.49277493 |
44 | keratan sulfate catabolic process (GO:0042340) | 3.48767794 |
45 | positive regulation of lipid catabolic process (GO:0050996) | 3.46651306 |
46 | regulation of triglyceride catabolic process (GO:0010896) | 3.45112058 |
47 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.44850815 |
48 | kynurenine metabolic process (GO:0070189) | 3.43026728 |
49 | growth hormone receptor signaling pathway (GO:0060396) | 3.42823646 |
50 | bile acid biosynthetic process (GO:0006699) | 3.39976079 |
51 | wound healing, spreading of epidermal cells (GO:0035313) | 3.38637157 |
52 | positive regulation of protein autophosphorylation (GO:0031954) | 3.36935819 |
53 | cellular response to vitamin (GO:0071295) | 3.34301887 |
54 | homocysteine metabolic process (GO:0050667) | 3.33754792 |
55 | positive regulation of fatty acid oxidation (GO:0046321) | 3.32752286 |
56 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.29691058 |
57 | tryptophan catabolic process (GO:0006569) | 3.29545110 |
58 | indole-containing compound catabolic process (GO:0042436) | 3.29545110 |
59 | indolalkylamine catabolic process (GO:0046218) | 3.29545110 |
60 | regulation of cholesterol storage (GO:0010885) | 3.27629601 |
61 | regulation of cholesterol homeostasis (GO:2000188) | 3.26874258 |
62 | endodermal cell differentiation (GO:0035987) | 3.24617603 |
63 | lysine metabolic process (GO:0006553) | 3.24147170 |
64 | lysine catabolic process (GO:0006554) | 3.24147170 |
65 | regulation of metalloenzyme activity (GO:0048552) | 3.23314045 |
66 | high-density lipoprotein particle remodeling (GO:0034375) | 3.22814858 |
67 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.22066293 |
68 | chondrocyte proliferation (GO:0035988) | 3.21612569 |
69 | tryptophan metabolic process (GO:0006568) | 3.19315413 |
70 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.19138145 |
71 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.15686258 |
72 | amino-acid betaine metabolic process (GO:0006577) | 3.13714590 |
73 | cellular response to vitamin D (GO:0071305) | 3.11002433 |
74 | acylglycerol homeostasis (GO:0055090) | 3.10006383 |
75 | triglyceride homeostasis (GO:0070328) | 3.10006383 |
76 | glyoxylate metabolic process (GO:0046487) | 3.09816528 |
77 | phospholipid homeostasis (GO:0055091) | 3.09161706 |
78 | protein localization to cell surface (GO:0034394) | 3.07282918 |
79 | barbed-end actin filament capping (GO:0051016) | 3.06103826 |
80 | fibroblast migration (GO:0010761) | 3.05942560 |
81 | diol metabolic process (GO:0034311) | 3.05483480 |
82 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.03599607 |
83 | cell-substrate junction assembly (GO:0007044) | 3.02919009 |
84 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 3.02127755 |
85 | blood vessel maturation (GO:0001955) | 3.01752048 |
86 | regulation of sequestering of triglyceride (GO:0010889) | 3.01142197 |
87 | reverse cholesterol transport (GO:0043691) | 3.00969404 |
88 | positive regulation of glycolytic process (GO:0045821) | 3.00752130 |
89 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.00167060 |
90 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.00120464 |
91 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.99824805 |
92 | bile acid metabolic process (GO:0008206) | 2.99406082 |
93 | cellular response to growth hormone stimulus (GO:0071378) | 2.99163693 |
94 | sprouting angiogenesis (GO:0002040) | 2.98596779 |
95 | sphingoid metabolic process (GO:0046519) | 2.98286474 |
96 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.98055093 |
97 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.98055093 |
98 | extracellular fibril organization (GO:0043206) | 2.96123064 |
99 | fatty acid transmembrane transport (GO:1902001) | 2.94425800 |
100 | type B pancreatic cell proliferation (GO:0044342) | 2.94380172 |
101 | negative regulation of fatty acid transport (GO:2000192) | 2.94255039 |
102 | negative regulation of cholesterol transport (GO:0032375) | 2.92434585 |
103 | negative regulation of sterol transport (GO:0032372) | 2.92434585 |
104 | glomerular visceral epithelial cell development (GO:0072015) | 2.91924148 |
105 | smooth muscle tissue development (GO:0048745) | 2.90557391 |
106 | triglyceride catabolic process (GO:0019433) | 2.89974539 |
107 | mesodermal cell differentiation (GO:0048333) | 2.89731986 |
108 | tyrosine metabolic process (GO:0006570) | 2.88331277 |
109 | fibrinolysis (GO:0042730) | 2.88251873 |
110 | cellular response to interferon-alpha (GO:0035457) | 2.88026334 |
111 | hypotonic response (GO:0006971) | 2.85950032 |
112 | ethanol oxidation (GO:0006069) | 2.85873753 |
113 | plasma lipoprotein particle remodeling (GO:0034369) | 2.85104664 |
114 | protein-lipid complex remodeling (GO:0034368) | 2.85104664 |
115 | macromolecular complex remodeling (GO:0034367) | 2.85104664 |
116 | positive regulation of fibroblast migration (GO:0010763) | 2.83563149 |
117 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.83266973 |
118 | hyaluronan catabolic process (GO:0030214) | 2.83215866 |
119 | protein hydroxylation (GO:0018126) | 2.82834100 |
120 | phospholipid efflux (GO:0033700) | 2.81568497 |
121 | serine family amino acid catabolic process (GO:0009071) | 2.81538646 |
122 | acylglycerol catabolic process (GO:0046464) | 2.81079986 |
123 | neutral lipid catabolic process (GO:0046461) | 2.81079986 |
124 | regulation of plasminogen activation (GO:0010755) | 2.80694332 |
125 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.80027164 |
126 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.77771282 |
127 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.77637206 |
128 | fatty acid beta-oxidation (GO:0006635) | 2.76788837 |
129 | fibril organization (GO:0097435) | 2.74975481 |
130 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.74632787 |
131 | lipoprotein metabolic process (GO:0042157) | 2.74158204 |
132 | epithelial cell-cell adhesion (GO:0090136) | 2.74156535 |
133 | endosome to melanosome transport (GO:0035646) | 2.73292132 |
134 | endosome to pigment granule transport (GO:0043485) | 2.73292132 |
135 | plasma lipoprotein particle assembly (GO:0034377) | 2.73178663 |
136 | fatty acid oxidation (GO:0019395) | 2.72660403 |
137 | linoleic acid metabolic process (GO:0043651) | 2.71517295 |
138 | protein-lipid complex assembly (GO:0065005) | 2.71271978 |
139 | acetyl-CoA metabolic process (GO:0006084) | 2.71257710 |
140 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.70545697 |
141 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.70368926 |
142 | endothelial cell morphogenesis (GO:0001886) | 2.69313942 |
143 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.69149551 |
144 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.68783875 |
145 | negative regulation of anoikis (GO:2000811) | 2.67709437 |
146 | apoptotic cell clearance (GO:0043277) | 2.67216094 |
147 | lipid oxidation (GO:0034440) | 2.65716597 |
148 | 2-oxoglutarate metabolic process (GO:0006103) | 2.65587229 |
149 | cell adhesion mediated by integrin (GO:0033627) | 2.64088825 |
150 | cholesterol efflux (GO:0033344) | 2.63091146 |
151 | vesicle coating (GO:0006901) | 2.61807089 |
152 | positive regulation of histone deacetylation (GO:0031065) | 2.60855091 |
153 | regulation of fatty acid oxidation (GO:0046320) | 2.60725864 |
154 | lymphangiogenesis (GO:0001946) | 2.60601979 |
155 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.60491538 |
156 | chondrocyte development (GO:0002063) | 2.59971417 |
157 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59866112 |
158 | complement activation (GO:0006956) | 2.59518532 |
159 | sterol homeostasis (GO:0055092) | 2.57442199 |
160 | cholesterol homeostasis (GO:0042632) | 2.57425066 |
161 | cellular glucuronidation (GO:0052695) | 2.56862946 |
162 | peptidyl-proline hydroxylation (GO:0019511) | 2.56653692 |
163 | regulation of lipid catabolic process (GO:0050994) | 2.56456625 |
164 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.56293525 |
165 | cellular modified amino acid catabolic process (GO:0042219) | 2.55791707 |
166 | negative regulation of lipid transport (GO:0032369) | 2.55680062 |
167 | aromatic amino acid family metabolic process (GO:0009072) | 2.54979577 |
168 | sphingomyelin metabolic process (GO:0006684) | 2.54442668 |
169 | import into cell (GO:0098657) | 2.52904497 |
170 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.51943128 |
171 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51311578 |
172 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.50827486 |
173 | negative regulation of adherens junction organization (GO:1903392) | 2.49109046 |
174 | negative regulation of focal adhesion assembly (GO:0051895) | 2.49109046 |
175 | negative regulation of cell junction assembly (GO:1901889) | 2.49109046 |
176 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.48239015 |
177 | negative regulation of stem cell proliferation (GO:2000647) | 2.47906447 |
178 | positive regulation of macrophage activation (GO:0043032) | 2.47199609 |
179 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.45885525 |
180 | collagen metabolic process (GO:0032963) | 2.44679985 |
181 | renal filtration (GO:0097205) | 2.43776165 |
182 | wound healing, spreading of cells (GO:0044319) | 2.42074926 |
183 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.40872054 |
184 | extracellular regulation of signal transduction (GO:1900115) | 2.40395367 |
185 | extracellular negative regulation of signal transduction (GO:1900116) | 2.40395367 |
186 | protein heterotrimerization (GO:0070208) | 2.40139894 |
187 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.38981759 |
188 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.38448384 |
189 | pericardium development (GO:0060039) | 2.37045984 |
190 | glomerular epithelial cell development (GO:0072310) | 2.35708848 |
191 | wound healing (GO:0042060) | 2.34696128 |
192 | muscle cell migration (GO:0014812) | 2.34528186 |
193 | positive regulation of endothelial cell migration (GO:0010595) | 2.32810284 |
194 | negative regulation of complement activation (GO:0045916) | 2.32515638 |
195 | membrane protein ectodomain proteolysis (GO:0006509) | 2.32442512 |
196 | regulation of protein autophosphorylation (GO:0031952) | 2.32106787 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.49720525 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.86642805 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.70104434 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.35549613 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.26195577 |
6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.13051742 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.23320234 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.18340254 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.95471018 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.81532839 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.72574762 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.64885853 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63526149 |
14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.60847663 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42573855 |
16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.37072432 |
17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09881006 |
18 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.08560980 |
19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.07676470 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.07481169 |
21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.07248432 |
22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04034471 |
23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03275817 |
24 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.87365759 |
25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.79502415 |
26 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.74483406 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73008916 |
28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71736043 |
29 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.70111730 |
30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67659171 |
31 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67094734 |
32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.65325487 |
33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.64850576 |
34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63196026 |
35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60815223 |
36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.59898741 |
37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58702876 |
38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.58579770 |
39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.52544413 |
40 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52387562 |
41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52295160 |
42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52132952 |
43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.51715983 |
44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49376697 |
45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47506063 |
46 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46376065 |
47 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44800347 |
48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44490964 |
49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42824393 |
50 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.37823379 |
51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37099098 |
52 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36737030 |
53 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36666160 |
54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36116001 |
55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35580957 |
56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34318716 |
57 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.32767061 |
58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30737460 |
59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30411714 |
60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28828880 |
61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27572392 |
62 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27518749 |
63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27198231 |
64 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26018852 |
65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25809809 |
66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23302605 |
67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22641367 |
68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.20827073 |
69 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.18028792 |
70 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16540557 |
71 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.16456578 |
72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16378356 |
73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15758995 |
74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13936458 |
75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13606580 |
76 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13606580 |
77 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.12105997 |
78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11864534 |
79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10967285 |
80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.10762412 |
81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10312299 |
82 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10163446 |
83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09513801 |
84 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.08880869 |
85 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08565134 |
86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07914862 |
87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07914862 |
88 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07492399 |
89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07472669 |
90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07186401 |
91 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05325369 |
92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04925437 |
93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04692318 |
94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04064974 |
95 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03851375 |
96 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03851375 |
97 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03805111 |
98 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02989311 |
99 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02620989 |
100 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02523428 |
101 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02429754 |
102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01742577 |
103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01335767 |
104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01213152 |
105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01186507 |
106 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99286594 |
107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96813938 |
108 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96791376 |
109 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96401821 |
110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96160521 |
111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95969920 |
112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95738411 |
113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95429586 |
114 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93380384 |
115 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92798963 |
116 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91902534 |
117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90953829 |
118 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90287766 |
119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89731294 |
120 | MYB_26560356_Chip-Seq_TH2_Human | 0.89318243 |
121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89026645 |
122 | MAF_26560356_Chip-Seq_TH1_Human | 0.88957386 |
123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88535831 |
124 | MYB_26560356_Chip-Seq_TH1_Human | 0.88292939 |
125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87872966 |
126 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87618369 |
127 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.87271256 |
128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87059473 |
129 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86322666 |
130 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86269057 |
131 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86096880 |
132 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85681646 |
133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84450134 |
134 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83796547 |
135 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.83085085 |
136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82789522 |
137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80657817 |
138 | ATF3_27146783_Chip-Seq_COLON_Human | 0.80456278 |
139 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79928981 |
140 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.79694476 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.62182500 |
2 | MP0008438_abnormal_cutaneous_collagen | 4.13601405 |
3 | MP0005360_urolithiasis | 4.05081853 |
4 | MP0003705_abnormal_hypodermis_morpholog | 3.59705337 |
5 | MP0003950_abnormal_plasma_membrane | 3.57281942 |
6 | MP0005365_abnormal_bile_salt | 3.57098700 |
7 | MP0005085_abnormal_gallbladder_physiolo | 3.06730721 |
8 | MP0005275_abnormal_skin_tensile | 2.91531144 |
9 | MP0003252_abnormal_bile_duct | 2.85921434 |
10 | MP0009780_abnormal_chondrocyte_physiolo | 2.67544902 |
11 | MP0010329_abnormal_lipoprotein_level | 2.45145087 |
12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.35444662 |
13 | MP0003300_gastrointestinal_ulcer | 2.28345124 |
14 | MP0005670_abnormal_white_adipose | 2.08831262 |
15 | MP0005257_abnormal_intraocular_pressure | 2.00898819 |
16 | MP0010352_gastrointestinal_tract_polyps | 1.97499748 |
17 | MP0003191_abnormal_cellular_cholesterol | 1.78015173 |
18 | MP0004185_abnormal_adipocyte_glucose | 1.77660070 |
19 | MP0003941_abnormal_skin_development | 1.76324484 |
20 | MP0005666_abnormal_adipose_tissue | 1.76176101 |
21 | MP0000609_abnormal_liver_physiology | 1.72147035 |
22 | MP0005503_abnormal_tendon_morphology | 1.68615616 |
23 | MP0009840_abnormal_foam_cell | 1.67069134 |
24 | MP0003566_abnormal_cell_adhesion | 1.65279329 |
25 | MP0005171_absent_coat_pigmentation | 1.61218923 |
26 | MP0004130_abnormal_muscle_cell | 1.60500003 |
27 | MP0002166_altered_tumor_susceptibility | 1.59463951 |
28 | MP0010234_abnormal_vibrissa_follicle | 1.58670876 |
29 | MP0001879_abnormal_lymphatic_vessel | 1.57294553 |
30 | MP0001542_abnormal_bone_strength | 1.56956464 |
31 | MP0005623_abnormal_meninges_morphology | 1.56537005 |
32 | MP0002138_abnormal_hepatobiliary_system | 1.55045511 |
33 | MP0005083_abnormal_biliary_tract | 1.51058344 |
34 | MP0002060_abnormal_skin_morphology | 1.47355548 |
35 | MP0002118_abnormal_lipid_homeostasis | 1.44909106 |
36 | MP0003806_abnormal_nucleotide_metabolis | 1.43568424 |
37 | MP0001666_abnormal_nutrient_absorption | 1.41538212 |
38 | MP0005023_abnormal_wound_healing | 1.34594459 |
39 | MP0003828_pulmonary_edema | 1.31961907 |
40 | MP0002254_reproductive_system_inflammat | 1.29990933 |
41 | MP0002877_abnormal_melanocyte_morpholog | 1.29147448 |
42 | MP0005076_abnormal_cell_differentiation | 1.28325860 |
43 | MP0005375_adipose_tissue_phenotype | 1.28085677 |
44 | MP0004272_abnormal_basement_membrane | 1.27647686 |
45 | MP0005332_abnormal_amino_acid | 1.26868032 |
46 | MP0009384_cardiac_valve_regurgitation | 1.24911525 |
47 | MP0001958_emphysema | 1.24847879 |
48 | MP0001661_extended_life_span | 1.23848049 |
49 | MP0003279_aneurysm | 1.23676028 |
50 | MP0006054_spinal_hemorrhage | 1.21435178 |
51 | MP0000015_abnormal_ear_pigmentation | 1.20772073 |
52 | MP0005165_increased_susceptibility_to | 1.18270455 |
53 | MP0003091_abnormal_cell_migration | 1.17312924 |
54 | MP0005164_abnormal_response_to | 1.16194181 |
55 | MP0003045_fibrosis | 1.14186129 |
56 | MP0005319_abnormal_enzyme/_coenzyme | 1.14095253 |
57 | MP0005409_darkened_coat_color | 1.13694529 |
58 | MP0002006_tumorigenesis | 1.09667239 |
59 | MP0001243_abnormal_dermal_layer | 1.08797596 |
60 | MP0002168_other_aberrant_phenotype | 1.08632556 |
61 | MP0002971_abnormal_brown_adipose | 1.08371831 |
62 | MP0002009_preneoplasia | 1.07317313 |
63 | MP0000598_abnormal_liver_morphology | 1.06280180 |
64 | MP0005595_abnormal_vascular_smooth | 1.05538762 |
65 | MP0010368_abnormal_lymphatic_system | 1.04262400 |
66 | MP0000371_diluted_coat_color | 1.03986678 |
67 | MP0004947_skin_inflammation | 1.02369322 |
68 | MP0000569_abnormal_digit_pigmentation | 1.00158528 |
69 | MP0009115_abnormal_fat_cell | 1.00127755 |
70 | MP0003436_decreased_susceptibility_to | 0.99935635 |
71 | MP0003195_calcinosis | 0.99766138 |
72 | MP0010307_abnormal_tumor_latency | 0.99271468 |
73 | MP0005174_abnormal_tail_pigmentation | 0.96652722 |
74 | MP0003868_abnormal_feces_composition | 0.95371529 |
75 | MP0009053_abnormal_anal_canal | 0.95220681 |
76 | MP0003453_abnormal_keratinocyte_physiol | 0.94974638 |
77 | MP0005508_abnormal_skeleton_morphology | 0.93654738 |
78 | MP0010386_abnormal_urinary_bladder | 0.93587694 |
79 | MP0000003_abnormal_adipose_tissue | 0.92918471 |
80 | MP0000383_abnormal_hair_follicle | 0.92813081 |
81 | MP0005334_abnormal_fat_pad | 0.92017442 |
82 | MP0004084_abnormal_cardiac_muscle | 0.89958742 |
83 | MP0009643_abnormal_urine_homeostasis | 0.87924605 |
84 | MP0002896_abnormal_bone_mineralization | 0.86512441 |
85 | MP0008004_abnormal_stomach_pH | 0.86316175 |
86 | MP0002928_abnormal_bile_duct | 0.84330224 |
87 | MP0004233_abnormal_muscle_weight | 0.84013159 |
88 | MP0009763_increased_sensitivity_to | 0.83605738 |
89 | MP0001881_abnormal_mammary_gland | 0.83551118 |
90 | MP0001533_abnormal_skeleton_physiology | 0.81560889 |
91 | MP0001348_abnormal_lacrimal_gland | 0.80730659 |
92 | MP0005647_abnormal_sex_gland | 0.80612425 |
93 | MP0010771_integument_phenotype | 0.80413277 |
94 | MP0001299_abnormal_eye_distance/ | 0.80141914 |
95 | MP0004019_abnormal_vitamin_homeostasis | 0.79927221 |
96 | MP0004134_abnormal_chest_morphology | 0.79198692 |
97 | MP0001851_eye_inflammation | 0.78477165 |
98 | MP0005501_abnormal_skin_physiology | 0.78373117 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77961078 |
100 | MP0000427_abnormal_hair_cycle | 0.76378780 |
101 | MP0000685_abnormal_immune_system | 0.76249834 |
102 | MP0000762_abnormal_tongue_morphology | 0.75913664 |
103 | MP0000733_abnormal_muscle_development | 0.75724101 |
104 | MP0000343_altered_response_to | 0.75476740 |
105 | MP0000604_amyloidosis | 0.75228138 |
106 | MP0002796_impaired_skin_barrier | 0.74188473 |
107 | MP0002295_abnormal_pulmonary_circulatio | 0.74105143 |
108 | MP0003303_peritoneal_inflammation | 0.73549198 |
109 | MP0008057_abnormal_DNA_replication | 0.73296089 |
110 | MP0005220_abnormal_exocrine_pancreas | 0.73068331 |
111 | MP0003656_abnormal_erythrocyte_physiolo | 0.70401394 |
112 | MP0002970_abnormal_white_adipose | 0.69996953 |
113 | MP0010678_abnormal_skin_adnexa | 0.69723063 |
114 | MP0005397_hematopoietic_system_phenotyp | 0.69392956 |
115 | MP0001545_abnormal_hematopoietic_system | 0.69392956 |
116 | MP0005464_abnormal_platelet_physiology | 0.69328547 |
117 | MP0001915_intracranial_hemorrhage | 0.68610146 |
118 | MP0002998_abnormal_bone_remodeling | 0.68546668 |
119 | MP0004883_abnormal_blood_vessel | 0.68470979 |
120 | MP0005197_abnormal_uvea_morphology | 0.67843369 |
121 | MP0009764_decreased_sensitivity_to | 0.67243569 |
122 | MP0000013_abnormal_adipose_tissue | 0.67006206 |
123 | MP0000377_abnormal_hair_follicle | 0.66558169 |
124 | MP0002108_abnormal_muscle_morphology | 0.65928322 |
125 | MP0001191_abnormal_skin_condition | 0.65813178 |
126 | MP0005390_skeleton_phenotype | 0.65412329 |
127 | MP0003724_increased_susceptibility_to | 0.65370784 |
128 | MP0005621_abnormal_cell_physiology | 0.65016298 |
129 | MP0005410_abnormal_fertilization | 0.65002649 |
130 | MP0000767_abnormal_smooth_muscle | 0.64981999 |
131 | MP0002128_abnormal_blood_circulation | 0.64758969 |
132 | MP0008469_abnormal_protein_level | 0.64476613 |
133 | MP0000249_abnormal_blood_vessel | 0.64029434 |
134 | MP0005408_hypopigmentation | 0.61449370 |
135 | MP0005058_abnormal_lysosome_morphology | 0.61411717 |
136 | MP0000627_abnormal_mammary_gland | 0.61408526 |
137 | MP0001756_abnormal_urination | 0.59294938 |
138 | MP0003448_altered_tumor_morphology | 0.59249620 |
139 | MP0001835_abnormal_antigen_presentation | 0.59234920 |
140 | MP0003795_abnormal_bone_structure | 0.58986897 |
141 | MP0001216_abnormal_epidermal_layer | 0.58905932 |
142 | MP0001614_abnormal_blood_vessel | 0.58628919 |
143 | MP0005388_respiratory_system_phenotype | 0.58406778 |
144 | MP0002133_abnormal_respiratory_system | 0.58406778 |
145 | MP0000465_gastrointestinal_hemorrhage | 0.58349505 |
146 | MP0002332_abnormal_exercise_endurance | 0.57973939 |
147 | MP0005395_other_phenotype | 0.57920949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.96228318 |
2 | Protrusio acetabuli (HP:0003179) | 4.12154976 |
3 | Xanthomatosis (HP:0000991) | 4.01135182 |
4 | Complement deficiency (HP:0004431) | 3.89666329 |
5 | Vascular tortuosity (HP:0004948) | 3.85902633 |
6 | Intrahepatic cholestasis (HP:0001406) | 3.83823886 |
7 | Myocardial infarction (HP:0001658) | 3.82601501 |
8 | Arterial tortuosity (HP:0005116) | 3.78280657 |
9 | Spondylolisthesis (HP:0003302) | 3.59528944 |
10 | Peritonitis (HP:0002586) | 3.56070265 |
11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.54029950 |
12 | Premature rupture of membranes (HP:0001788) | 3.47122300 |
13 | Epidermoid cyst (HP:0200040) | 3.33399113 |
14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.23653393 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.22667629 |
16 | Short nail (HP:0001799) | 3.15251176 |
17 | Hyperlipoproteinemia (HP:0010980) | 3.08482255 |
18 | Ankle contracture (HP:0006466) | 3.07410555 |
19 | Wormian bones (HP:0002645) | 3.03761899 |
20 | Hypobetalipoproteinemia (HP:0003563) | 3.00143217 |
21 | Aortic aneurysm (HP:0004942) | 2.95496915 |
22 | Abnormality of complement system (HP:0005339) | 2.93988998 |
23 | Hypoalphalipoproteinemia (HP:0003233) | 2.89008986 |
24 | Vertebral compression fractures (HP:0002953) | 2.88466818 |
25 | Aortic dissection (HP:0002647) | 2.85960783 |
26 | Mitral valve prolapse (HP:0001634) | 2.85693324 |
27 | Cerebral aneurysm (HP:0004944) | 2.85310762 |
28 | Prolonged partial thromboplastin time (HP:0003645) | 2.85007533 |
29 | Absent frontal sinuses (HP:0002688) | 2.77503437 |
30 | Hypolipoproteinemia (HP:0010981) | 2.75117288 |
31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.69189323 |
32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.68578897 |
33 | Hypercholesterolemia (HP:0003124) | 2.65822155 |
34 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.63372703 |
35 | Overgrowth (HP:0001548) | 2.60890114 |
36 | Mitral stenosis (HP:0001718) | 2.59325004 |
37 | Shallow orbits (HP:0000586) | 2.58719960 |
38 | Hypoglycemic coma (HP:0001325) | 2.58578949 |
39 | Broad metatarsal (HP:0001783) | 2.56939349 |
40 | Hemorrhage of the eye (HP:0011885) | 2.55984800 |
41 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.54525835 |
42 | Glucose intolerance (HP:0000833) | 2.50276085 |
43 | Increased mean platelet volume (HP:0011877) | 2.49242744 |
44 | Aortic regurgitation (HP:0001659) | 2.48428833 |
45 | Skin nodule (HP:0200036) | 2.47580257 |
46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.45323485 |
47 | Esophageal varix (HP:0002040) | 2.43896813 |
48 | Joint hemorrhage (HP:0005261) | 2.40236519 |
49 | Spinal rigidity (HP:0003306) | 2.39920000 |
50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36894733 |
51 | Ketosis (HP:0001946) | 2.34645270 |
52 | Hyperammonemia (HP:0001987) | 2.34363246 |
53 | Tetraparesis (HP:0002273) | 2.34249113 |
54 | Dilatation of the ascending aorta (HP:0005111) | 2.33020432 |
55 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.30717147 |
56 | Cervical subluxation (HP:0003308) | 2.30611375 |
57 | Spinal cord lesions (HP:0100561) | 2.28440819 |
58 | Syringomyelia (HP:0003396) | 2.28440819 |
59 | Aneurysm (HP:0002617) | 2.26420504 |
60 | Elbow flexion contracture (HP:0002987) | 2.24342424 |
61 | Cardiovascular calcification (HP:0011915) | 2.23169155 |
62 | Atrophic scars (HP:0001075) | 2.22733541 |
63 | Ectopia lentis (HP:0001083) | 2.22404284 |
64 | Abnormal platelet volume (HP:0011876) | 2.22325514 |
65 | Natal tooth (HP:0000695) | 2.21643447 |
66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.19522898 |
67 | Spinal cord compression (HP:0002176) | 2.18747445 |
68 | Entropion (HP:0000621) | 2.15690672 |
69 | Abnormality of the frontal sinuses (HP:0002687) | 2.13555582 |
70 | Aortic valve stenosis (HP:0001650) | 2.12031684 |
71 | Abnormality of the acetabulum (HP:0003170) | 2.12003001 |
72 | Hepatocellular carcinoma (HP:0001402) | 2.11849385 |
73 | Subacute progressive viral hepatitis (HP:0006572) | 2.08395475 |
74 | Abnormality of proline metabolism (HP:0010907) | 2.08310106 |
75 | Hydroxyprolinuria (HP:0003080) | 2.08310106 |
76 | Follicular hyperkeratosis (HP:0007502) | 2.07564671 |
77 | Hematochezia (HP:0002573) | 2.06817739 |
78 | Spastic diplegia (HP:0001264) | 2.06467101 |
79 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.05312727 |
80 | Hypoplasia of the iris (HP:0007676) | 2.04215626 |
81 | Ulnar bowing (HP:0003031) | 2.03299591 |
82 | Fat malabsorption (HP:0002630) | 2.02005251 |
83 | Ovoid vertebral bodies (HP:0003300) | 2.01046485 |
84 | Abnormal glucose tolerance (HP:0001952) | 2.00756807 |
85 | Right ventricular cardiomyopathy (HP:0011663) | 2.00429443 |
86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00364466 |
87 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00364466 |
88 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00364466 |
89 | Abnormal cartilage morphology (HP:0002763) | 2.00347881 |
90 | Blue sclerae (HP:0000592) | 1.99792969 |
91 | Abnormality of carpal bone ossification (HP:0006257) | 1.99361056 |
92 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.98414578 |
93 | Hypertriglyceridemia (HP:0002155) | 1.98164224 |
94 | Macroorchidism (HP:0000053) | 1.96163427 |
95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95759640 |
96 | Abnormality of glycine metabolism (HP:0010895) | 1.95759640 |
97 | Increased connective tissue (HP:0009025) | 1.95141891 |
98 | Gingival bleeding (HP:0000225) | 1.94929829 |
99 | Persistence of primary teeth (HP:0006335) | 1.93616573 |
100 | Lymphangioma (HP:0100764) | 1.93429551 |
101 | Joint laxity (HP:0001388) | 1.91474718 |
102 | Abnormality of oral frenula (HP:0000190) | 1.91419816 |
103 | Hyperglycinuria (HP:0003108) | 1.90651847 |
104 | Acanthosis nigricans (HP:0000956) | 1.90490043 |
105 | Relative macrocephaly (HP:0004482) | 1.89822970 |
106 | Knee flexion contracture (HP:0006380) | 1.89261211 |
107 | * Osteolytic defects of the hand bones (HP:0009699) | 1.88554499 |
108 | * Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.88554499 |
109 | Metaphyseal dysplasia (HP:0100255) | 1.86465628 |
110 | Turricephaly (HP:0000262) | 1.85952810 |
111 | Abnormality of the peritoneum (HP:0002585) | 1.84913110 |
112 | Onycholysis (HP:0001806) | 1.84608598 |
113 | Abnormal auditory evoked potentials (HP:0006958) | 1.84607506 |
114 | Asymmetry of the thorax (HP:0001555) | 1.82973079 |
115 | Striae distensae (HP:0001065) | 1.82361681 |
116 | Nephritis (HP:0000123) | 1.81310444 |
117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80890594 |
118 | Albinism (HP:0001022) | 1.80583822 |
119 | Genu recurvatum (HP:0002816) | 1.80508302 |
120 | Hyperextensible skin (HP:0000974) | 1.79631262 |
121 | Vascular calcification (HP:0004934) | 1.79496414 |
122 | Ankyloglossia (HP:0010296) | 1.78934560 |
123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78679598 |
124 | Mucopolysacchariduria (HP:0008155) | 1.78679598 |
125 | Abnormality of skull ossification (HP:0002703) | 1.78095276 |
126 | Enlarged penis (HP:0000040) | 1.77833096 |
127 | Abnormal ossification of hand bones (HP:0005921) | 1.76637185 |
128 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.76177152 |
129 | Hyperglycinemia (HP:0002154) | 1.76119601 |
130 | Bladder diverticulum (HP:0000015) | 1.75975100 |
131 | Wrist flexion contracture (HP:0001239) | 1.75923811 |
132 | Disproportionate tall stature (HP:0001519) | 1.75553474 |
133 | Alopecia of scalp (HP:0002293) | 1.75338499 |
134 | Abnormal delivery (HP:0001787) | 1.74478645 |
135 | Decreased skull ossification (HP:0004331) | 1.74437140 |
136 | Abnormality of methionine metabolism (HP:0010901) | 1.74430589 |
137 | Soft skin (HP:0000977) | 1.74338053 |
138 | Abnormality of dentin (HP:0010299) | 1.74098648 |
139 | Delayed cranial suture closure (HP:0000270) | 1.74023703 |
140 | Polycythemia (HP:0001901) | 1.74017488 |
141 | Systemic lupus erythematosus (HP:0002725) | 1.73931129 |
142 | Periodontitis (HP:0000704) | 1.73240496 |
143 | Abnormality of purine metabolism (HP:0004352) | 1.72561461 |
144 | Slender build (HP:0001533) | 1.72455940 |
145 | Abnormal hand bone ossification (HP:0010660) | 1.72230369 |
146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71893087 |
147 | Abnormality of the 4th metacarpal (HP:0010012) | 1.70590069 |
148 | Broad face (HP:0000283) | 1.70376107 |
149 | Back pain (HP:0003418) | 1.70160500 |
150 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.69995033 |
151 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.69969050 |
152 | Short 4th metacarpal (HP:0010044) | 1.69969050 |
153 | Rectal prolapse (HP:0002035) | 1.69050995 |
154 | Abnormality of Sharpey fibers (HP:0100685) | 1.69038885 |
155 | Coarse hair (HP:0002208) | 1.68179269 |
156 | Camptodactyly of toe (HP:0001836) | 1.68119668 |
157 | Increased density of long bones (HP:0006392) | 1.68049912 |
158 | Cutaneous melanoma (HP:0012056) | 1.67610413 |
159 | Mesomelia (HP:0003027) | 1.67185476 |
160 | Chondrocalcinosis (HP:0000934) | 1.67074511 |
161 | Gastrointestinal infarctions (HP:0005244) | 1.66292386 |
162 | Acanthocytosis (HP:0001927) | 1.66211655 |
163 | Dysostosis multiplex (HP:0000943) | 1.65647241 |
164 | Hamartoma of the eye (HP:0010568) | 1.65502814 |
165 | Ketoacidosis (HP:0001993) | 1.65234514 |
166 | Infantile muscular hypotonia (HP:0008947) | 1.64544329 |
167 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.64285846 |
168 | Tibial bowing (HP:0002982) | 1.64119569 |
169 | Fragile skin (HP:0001030) | 1.64026566 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SIK1 | 3.70510471 |
2 | TRIB3 | 3.65244521 |
3 | MYLK | 2.88543874 |
4 | LATS1 | 2.86362963 |
5 | MST4 | 2.77158555 |
6 | ERN1 | 2.73993725 |
7 | PKN2 | 2.64413786 |
8 | FGFR4 | 2.52043398 |
9 | CAMK1D | 2.47558933 |
10 | FRK | 2.36755693 |
11 | FGFR2 | 2.26373433 |
12 | RIPK1 | 2.01166706 |
13 | PDGFRA | 1.98501517 |
14 | TTN | 1.95672213 |
15 | EIF2AK3 | 1.92789985 |
16 | FGFR3 | 1.91058390 |
17 | CAMK1G | 1.84285456 |
18 | PTK6 | 1.83814090 |
19 | NEK9 | 1.82051183 |
20 | EEF2K | 1.80770488 |
21 | STK3 | 1.75662335 |
22 | TIE1 | 1.74933740 |
23 | ERBB3 | 1.74628180 |
24 | MAP3K12 | 1.71036341 |
25 | CDK12 | 1.67213845 |
26 | LIMK1 | 1.66873341 |
27 | JAK1 | 1.65704582 |
28 | FLT3 | 1.61966034 |
29 | DDR2 | 1.61833813 |
30 | CDK6 | 1.61607791 |
31 | EIF2AK1 | 1.59617654 |
32 | BRSK2 | 1.58042593 |
33 | EPHB1 | 1.57271479 |
34 | TRIM28 | 1.53679993 |
35 | IRAK3 | 1.50675631 |
36 | EPHA2 | 1.47489474 |
37 | TYK2 | 1.47381298 |
38 | BCKDK | 1.44143420 |
39 | AKT3 | 1.43948129 |
40 | TAOK3 | 1.41108059 |
41 | EPHA3 | 1.40055202 |
42 | JAK3 | 1.39062122 |
43 | LRRK2 | 1.36635724 |
44 | PBK | 1.36176662 |
45 | MAP3K10 | 1.34992358 |
46 | PDK4 | 1.28077708 |
47 | PDK3 | 1.28077708 |
48 | LATS2 | 1.24577254 |
49 | ACVR1B | 1.23197259 |
50 | BMPR2 | 1.20367741 |
51 | TGFBR2 | 1.20046857 |
52 | PDGFRB | 1.16862482 |
53 | SIK3 | 1.16840762 |
54 | STK10 | 1.16777120 |
55 | STK38L | 1.14688052 |
56 | TRPM7 | 1.11917098 |
57 | MTOR | 1.11741624 |
58 | MST1R | 1.10899491 |
59 | MOS | 1.09450283 |
60 | INSRR | 1.08353624 |
61 | BMX | 1.08054393 |
62 | MAPKAPK3 | 1.07797225 |
63 | STK38 | 1.05430564 |
64 | ICK | 1.04464036 |
65 | PAK2 | 1.00996031 |
66 | FGFR1 | 0.98889180 |
67 | STK39 | 0.97807272 |
68 | RET | 0.96667099 |
69 | TESK1 | 0.95694723 |
70 | TGFBR1 | 0.95610829 |
71 | PTK2 | 0.93631586 |
72 | MET | 0.93340418 |
73 | JAK2 | 0.92922484 |
74 | ILK | 0.91424500 |
75 | CSF1R | 0.90868491 |
76 | SCYL2 | 0.88015158 |
77 | MAP3K14 | 0.86946531 |
78 | ABL2 | 0.85923758 |
79 | RPS6KA4 | 0.84724328 |
80 | MAP2K3 | 0.80962058 |
81 | TBK1 | 0.80757492 |
82 | DYRK1B | 0.79561464 |
83 | ZAP70 | 0.78787415 |
84 | MAP3K2 | 0.75745709 |
85 | MAP2K1 | 0.75713599 |
86 | STK24 | 0.75207541 |
87 | CAMKK2 | 0.75187802 |
88 | PLK2 | 0.74694926 |
89 | PRKAA2 | 0.74674311 |
90 | CHUK | 0.74179883 |
91 | TSSK6 | 0.72553011 |
92 | MAP3K7 | 0.71961731 |
93 | NUAK1 | 0.71464057 |
94 | NEK1 | 0.71384259 |
95 | BCR | 0.70465350 |
96 | CDK4 | 0.68810815 |
97 | MAP4K1 | 0.67348587 |
98 | MAPK11 | 0.66438523 |
99 | ITK | 0.65778890 |
100 | CSK | 0.65597012 |
101 | FER | 0.64808394 |
102 | MAP3K6 | 0.63924360 |
103 | PRKD2 | 0.63633346 |
104 | MAP3K3 | 0.61365432 |
105 | PAK3 | 0.59522233 |
106 | KIT | 0.58292106 |
107 | GSK3A | 0.57480053 |
108 | CDK9 | 0.56939274 |
109 | BMPR1B | 0.56771400 |
110 | PDK2 | 0.56574490 |
111 | CLK1 | 0.56150589 |
112 | NEK2 | 0.54249300 |
113 | ROCK1 | 0.53728864 |
114 | ADRBK1 | 0.52676512 |
115 | KSR1 | 0.52552753 |
116 | SGK3 | 0.52202054 |
117 | TEC | 0.51758673 |
118 | DMPK | 0.51333518 |
119 | PTK2B | 0.50506837 |
120 | EGFR | 0.49995730 |
121 | ROCK2 | 0.49694919 |
122 | IGF1R | 0.49112126 |
123 | PIK3CG | 0.48731276 |
124 | PIK3CA | 0.48207129 |
125 | PRKCH | 0.47303734 |
126 | ERBB4 | 0.47248617 |
127 | STK4 | 0.45051920 |
128 | PDK1 | 0.43488838 |
129 | PDPK1 | 0.42057319 |
130 | MELK | 0.42005600 |
131 | INSR | 0.41626883 |
132 | PRKCE | 0.41308373 |
133 | CDK8 | 0.41232370 |
134 | PAK4 | 0.40841040 |
135 | WNK1 | 0.40797552 |
136 | IKBKB | 0.40415486 |
137 | PRKG2 | 0.39842263 |
138 | PRKD3 | 0.39722087 |
139 | PLK3 | 0.39398224 |
140 | MAP3K8 | 0.38407333 |
141 | MAPKAPK5 | 0.38235530 |
142 | MAPKAPK2 | 0.37975172 |
143 | ABL1 | 0.36933757 |
144 | ERBB2 | 0.35908655 |
145 | HCK | 0.35437846 |
146 | EPHB2 | 0.35135386 |
147 | PRKCI | 0.35071578 |
148 | TAF1 | 0.34975064 |
149 | IKBKE | 0.34640319 |
150 | NEK6 | 0.34329554 |
151 | PRKCQ | 0.34050249 |
152 | LMTK2 | 0.33714608 |
153 | PIM1 | 0.33457951 |
154 | EIF2AK2 | 0.33244629 |
155 | NTRK1 | 0.32768914 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61105149 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.29351926 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.64585493 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54239512 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.45466961 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45075620 |
7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.44506759 |
8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.39731331 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.23209019 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15056498 |
11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10695587 |
12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08222744 |
13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.04083863 |
14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.03736064 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00601878 |
16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.00518482 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92464748 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.91357541 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86413040 |
20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.85851841 |
21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82914290 |
22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.71823528 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69517760 |
24 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.58310255 |
25 | Melanoma_Homo sapiens_hsa05218 | 1.55145482 |
26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54293088 |
27 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.47761703 |
28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46665171 |
29 | Peroxisome_Homo sapiens_hsa04146 | 1.41352280 |
30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.39018539 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38841432 |
32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.38528494 |
33 | Lysosome_Homo sapiens_hsa04142 | 1.37316507 |
34 | Thyroid cancer_Homo sapiens_hsa05216 | 1.33023509 |
35 | Lysine degradation_Homo sapiens_hsa00310 | 1.31377973 |
36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.31362943 |
37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27977378 |
38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.26838352 |
39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24287418 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.23680118 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.21695566 |
42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19203458 |
43 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.18523128 |
44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17019109 |
45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16519107 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.16322234 |
47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13995200 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12935976 |
49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.12194110 |
50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10633651 |
51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.09082431 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07257732 |
53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06773696 |
54 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.06137821 |
55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03071951 |
56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02590206 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02259671 |
58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02187741 |
59 | Insulin resistance_Homo sapiens_hsa04931 | 1.01107877 |
60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00585485 |
61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00251120 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99669546 |
63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97071532 |
64 | Pathways in cancer_Homo sapiens_hsa05200 | 0.94538680 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92072043 |
66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91965633 |
67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91225363 |
68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89535974 |
69 | Glioma_Homo sapiens_hsa05214 | 0.88770665 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87597340 |
71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86835567 |
72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84215948 |
73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84022003 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78070753 |
75 | Focal adhesion_Homo sapiens_hsa04510 | 0.76102888 |
76 | Endocytosis_Homo sapiens_hsa04144 | 0.75698063 |
77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75195437 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73901218 |
79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73571568 |
80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70788261 |
81 | Phagosome_Homo sapiens_hsa04145 | 0.70541330 |
82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68682963 |
83 | Hepatitis B_Homo sapiens_hsa05161 | 0.68395340 |
84 | Amoebiasis_Homo sapiens_hsa05146 | 0.67217645 |
85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67183958 |
86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67116169 |
87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66426675 |
88 | Adherens junction_Homo sapiens_hsa04520 | 0.65933775 |
89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65844096 |
90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65804078 |
91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65013020 |
92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64920851 |
93 | Tight junction_Homo sapiens_hsa04530 | 0.63262496 |
94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62653112 |
95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62353353 |
96 | Mineral absorption_Homo sapiens_hsa04978 | 0.61198019 |
97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58978232 |
98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58449163 |
99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57216219 |
100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57131527 |
101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55594144 |
102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55436356 |
103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55395024 |
104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55289887 |
105 | Salmonella infection_Homo sapiens_hsa05132 | 0.54756369 |
106 | Protein export_Homo sapiens_hsa03060 | 0.54696078 |
107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54427997 |
108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54421300 |
109 | Pertussis_Homo sapiens_hsa05133 | 0.54268701 |
110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53896386 |
111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52207077 |
112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50791090 |
113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48037276 |
114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47878699 |
115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47667960 |
116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47454127 |
117 | Apoptosis_Homo sapiens_hsa04210 | 0.46500697 |
118 | Legionellosis_Homo sapiens_hsa05134 | 0.46096400 |
119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45855573 |
120 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45760830 |
121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44956643 |
122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44374513 |
123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44274839 |
124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43737443 |
125 | Malaria_Homo sapiens_hsa05144 | 0.43631160 |
126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42722311 |
127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41279449 |
128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41091859 |
129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40918088 |
130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40886623 |
131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40794340 |
132 | Gap junction_Homo sapiens_hsa04540 | 0.39590459 |
133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39152550 |
134 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38064827 |
135 | Leishmaniasis_Homo sapiens_hsa05140 | 0.38018618 |
136 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37777876 |
137 | Bladder cancer_Homo sapiens_hsa05219 | 0.37539230 |
138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37402706 |
139 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37097307 |
140 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36301166 |
141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35960159 |
142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35823996 |
143 | Prostate cancer_Homo sapiens_hsa05215 | 0.35804227 |
144 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35708925 |
145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35453073 |
146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34618342 |
147 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34275732 |
148 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34156892 |
149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33134943 |
150 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32937441 |
151 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32936544 |
152 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32890161 |
153 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31646859 |
154 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31317689 |
155 | Measles_Homo sapiens_hsa05162 | 0.29124907 |
156 | Platelet activation_Homo sapiens_hsa04611 | 0.27919527 |
157 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27003572 |
158 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.26887332 |
159 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26691875 |
160 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26520512 |
161 | Hepatitis C_Homo sapiens_hsa05160 | 0.26269017 |